Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

Not everybody with blockages needs surgical intervention. Guidelines recommend against surgery in people with no symptoms and ...

The findings from this single-center retrospective study compare outcomes between 2 groups of patients living with connective ...

A board certified cardiologist has shared a list of the seven most common signs and symptoms to look out for as it could mean ...

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

The PAH Initiative is hosting a video event in May to provide information about exercise benefits for PAH patients.

Hypertension does not directly cause dyspnoea; however it can lead to long-term effects on the heart and arteries ...

Systemic lupus erythematosus is associated with an increased risk for pulmonary manifestations, including ILD and pulmonary hypertension.

Corvista Health’s point-of-care device, used to predict pulmonary hypertension (PH), also appears to work well at identifying ...

Dr Ahmed Fahim discusses the UK Idiopathic Pulmonary Fibrosis Registry and how its findings enhance understanding and ...

A recent publication by the British Thoracic Society offers the first long-term analysis of the UK Idiopathic Pulmonary ...